# Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Study · id `cardio:ct-nct05955326` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05955326](<https://clinicaltrials.gov/study/NCT05955326>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05955326

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT05955326. Randomized; quadruple masking; primary purpose treatment. Start 2024-01-08 (actual); primary completion 2026-12-18 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT05955326, source copy `cardio:ctgov-nct05955326-2026-09-29`, retrieved 2026-10-26)
- Started: 2024-01-08 (actual) (ClinicalTrials.gov record NCT05955326, source copy `cardio:ctgov-nct05955326-2026-09-29`, retrieved 2026-10-26)
- Primary completion: 2026-12-18 (anticipated) (ClinicalTrials.gov record NCT05955326, source copy `cardio:ctgov-nct05955326-2026-09-29`, retrieved 2026-10-26)
- Completion: 2026-12-18 (anticipated) (ClinicalTrials.gov record NCT05955326, source copy `cardio:ctgov-nct05955326-2026-09-29`, retrieved 2026-10-26)
- Countries: India (ClinicalTrials.gov record NCT05955326, source copy `cardio:ctgov-nct05955326-2026-09-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05955326-2026-09-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- Condition: Acute Cerebral Ischemia
- Intervention (Drug): Sovateltide
- Intervention (Other): Normal Saline
- Lead sponsor: Pharmazz, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Pharmazz, Inc. (`cardio:org-pharmazz-inc`)

## Provenance

Content hash: 9cefeb3650f1b3f5ce010cd0e1494a880c0a36f18e71e36c8f43955d6c96b4be
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
